To further evaluate whether mTOR could serve as a potential diagnostic and/or prognostic biomarker for AA PCa (or PCa in general), IHC assays were performed to examine the mTOR expression levels in PCa specimens derived from two independent cohorts of PCa patients. Here, MTOR is linked to posterior cortical atrophy.